Fujifilm Diosynth CEO Martin Meeson at BIO22 (J.T. MacMillan Photography for Endpoints News)
March 1, 2023 03:52 PM EST
Manufacturing

Q&A: Fu­ji­film Diosynth CEO Mar­tin Mee­son says com­pa­ny is in 'growth mod­e'

Tyler Patchen

News Reporter

Fu­ji­film Diosynth had a busy 2022, in­vest­ing more than $1 bil­lion in­to its man­u­fac­tur­ing sites while ex­pand­ing its glob­al foot­print.

The com­pa­ny is a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times